Testimonials and Navigation in Rheumatology
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alabama at Birmingham
About this trial
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
Eligibility criteria
Qualifiers
Adults (18+ years) with known AIRD
Black race and/or Latinx ethnicity
Individuals who have not obtained the updated COVID-19 vaccine series (self-report)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences
- Video on the importance of good oral health for patients with AIRD
- Brochure on COVID-19 vaccination in AIRD patients
- Patient Navigation
- Brochure on the importance of good oral health in AIRD patients
Treatment groups
1,170 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Alabama at Birmingham
Lead sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
Source ClinicalTrials.gov